Botswana News

Botswana’s participation at the World Health Assembly 2022

On the occasion of the 75th session of the World Health Assembly (taking place in Geneva between 22-28 May 2022), His Excellency Dr Mokgweetsi E.K. Masisi, President of the Republic of Botswana shared Botswana’s health trajectory, particularly in the midst of country’s efforts to recover from the COVID-19 pandemic.

Regain lost ground on vaccine-preventable diseases in Botswana

Gaborone, 28 April 2022 – Pandemic-related disruptions, increasing inequalities in access to vaccines, and the COVID-19-related diversion of resources from routine immunization are leaving too many children without protection against vaccine-preventable diseases. As Botswana joins the world in celebrating World Immunization Week and the historic achievements through vaccines, the country needs to urgently turn the spotlight to routine immunization against common childhood diseases, such as measles.

An HIV-negative start in life thanks to Botswana’s pathbreaking programme

Seventeen-year-old Keneilwe dreams of someday becoming a pharmacist. “There was a shortage of pharmacists at my clinic, and always long lines,” she recalls of previous visits. “I thought I could help them.” Keneilwe grew up watching her mother, Cecilia, take daily medication prescribed by the clinic. “I thought it was for blood pressure,” she says.

Botswana is first country with severe HIV epidemic to reach key milestone in the eli...

Botswana has become the first high-burden country to be certified for achieving an important milestone on the path to eliminating mother-to-child transmission of HIV by the World Health Organization (WHO). High-burden HIV countries are defined as those with more than 2% of pregnant women living with the virus. Botswana has achieved the “silver tier” status, which moves it closer to eliminating mother-to-child HIV transmission. WHO awards this certification to countries which have brought the mother-to-child HIV transmission rate to under 5 %; provided antenatal care and antiretroviral treatment to more than 90 % of pregnant women; and achieved an HIV case rate of fewer than 500 per 100,000 live births.